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Acti vity of a d enosin e 3',5 ' -cyc li c monophosphate-depend en t prote in kinase has bee n 
m easured in t he sk in of nor m a l con t ro ls, pa ti e nt s wi t h non-atopic skin disord ers, a nd t hose 
wit h atop ic d ermat it is. All samples a na lyzed displayed t he prese nce of t his e nzy m atic 
activ ity . H owever , t he enzym e from t he ato pic s kin di d not seem to be d epend ent on cycli c 
AMP for act ivity. Whether t his is du e to a n a r t ifact of isolat ion of prote in kinase or is indeed 
t he t ru e in v ivo nature of t h e enzy m e rem a ins to be esta blis hed . 
According to Szen t iva ny i [11, a to py is a n a dre-
n ergic imba la nce ca used by a n increase in a lpha 
adrenergic act ivi ty a nd a d ecrease in beta a drener-
gic ac tiv ity or both . Al t hough only t he asthm atic 
m a n ifes tat ions of a topy were hi s m a in cons idera-
tions, Szentiva nyi con ceded t hat his theory could 
a p ply eq u a lly well to other cl ini ca l ex press ions of 
atopy . T his conce pt cons iders t h e cyc lic AMP 
system as t he probab le s ite of t he bioc he mi ca l 
lesion in atopy (atop ic d erm atit is). 
In support of t hi s t heory, asthmatics ex hibi t less 
in crease in urin a ry cyc lic AMP in compa ri son to 
norm a l subj ects whe n cha ll enged by e pine phrine 
[2,3 ]. Asthmatics a lso di splay a m a lfunction in 
plate let aggregation a fte r st imul at ion by epineph -
rine, su ggestin g a lt ered adrenergic receptors in 
t heir pl a t e lets [4 ]. S imil a rly, leukocytes of patie n ts 
wi t h ato pic ecze m a or asthma m a nifest a lowered 
response to beta a drenergic stimulat ion by iso-
p rote renol [5,7 ]. P rev ious studies resul t in g in d e-
tection of lower leve ls of catechola mines in t he 
plasm a [8] a nd t he ir a lte red disposition in t he skin 
of patients wit h atopic derm at it is [9 ] a lso susta in 
t he postul ates later suggested by Szen t ivany i [1]. 
On t he oth er ha nd , norm a l act ivit ies of a deny l-
a t e cyclase [10], cyclic AMP phosphodi est e rase 
[11], a nd cycli c AM P-d ependent prote in kinase 
[12 J have been found in skin biops ies from patients 
wi t h atopic derm atit is . 
In t his commun ication , we report t h e resul ts of 
our investigations on cyclic AMP-d ependen t pro-
tein kinase activ ity in t he skin of norm a l subjects, 
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a nd that of pa tie nts wi t h non -a topi c skin di sorde r s 
a nd atopic d ermatitis . In con t rast t o the re port o f 
Mie r a nd co-workers [12 ], we observed t hat prote in 
kin ase of ato pic s kin exhibi ted relat ively small Or 
no s timula tion of enzym e ac ti vity in t he presen e 
of cyclic AMP wh en compa red to t he t wo ty pes of 
co nt rols we e m ployed. This observation suggests 
t h e presen ce of a n a lte red en zy matic en t ity Or 
enti t ies in t he skin of pa ti en ts with a topic d ermat i_ 
t is. 
MATERI ALS AN D MET HODS 
Pun ch biopsies (4- mm ) of skin from non-a to pic a nd 
ato pic patients were acquired from the Derm atology 
Clini c of t he Uni versity Hospital. Inform ed consent was 
secured from eac h patient. Freshly excised clini cally 
norm al skin was obta ined from the opera ting roo m. 
"(- I" P IATP and ' H-la beled cycli c AMP were pur- · 
chased from New England Nuclear Corporation. Histone 
cyclic AMP , and the other cyclic nu cleotides were th~ 
prod ucts of S igma Chemica l Company or P- L Biochemi _ 
cals. 
Assays for protein kinase ac tivi ty and cyclic AMP _ 
bindin g activity were performed as desc ribed in deta il 
prev iously [13, 14). Specific act ivi ty of t he enzy me was 
ex pressed as pi comoles of " 1' incorporated into histon e 
by 1.0 mg of enzy me per 10 min incubation at 37 °C 
P rotein conce ntration was determined by the method of 
Lowry et a l [15 ] us ing bov ine serum albumin as t h e 
stand ard . . 
En.zym e p urification. . All operations were performed at 
2- 4°C. Skin cleaned of subcutaneous tissue was pulver _ 
ized in a steel mortar and pestle cooled in liquid nitrogen . 
The powder was suspended in 0.5 ml of cold 0.02 M 
Tris- HC1, pH 7.5, conta ining 1 mM dithithreitol (Buffe t 
A) a nd sonica ted for 5 sec. The resultant solut ion was 
centrifuged at 105,000 x g for 90 min and the supernatan t 
treated as previously reported [13, 14 J, successively wi t h 
1 % streptomyc in sulfa te and 50% ammonium sulfate to 
isolate the enzy me. Protein kinase and cyclic AM P 
binding ac tivities as well as protein concentration were 
determined on this preparation after exhaustive dia lysis 
against Buffer A. 
RESULTS AND DISCUSSION 
Figure 1 s um m a rizes the protein kinase activi ty 
in the skin of norma l, non-a topic, and a t opic 
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F I G. 1. Cycli c AMP·dependent prote in kinase activ ity 
in t h e skin of norm al, non·a topic, and atopic subjects. 
B iopsies 0 (' non·atopic and atopic pat ients were taken 
from active lesions. The enzyme act ivity was measured as 
descr ibed prev iously [13, 14]. The average enzyme con· 
cen t r ation in the assay was 0.61 mg per ml of normal , 0.54 
mg per ml of non·atopic, and 0. 13 mg per ml of atop ic 
p reparation. Kinase activity is ex pressed as pico moles 0 (' 
32p in corporated in to histone by 1.0 mg of enzy me per 
10-m in incubation at 37 °C. Spec ific activi ty of 'Y' I" P] 
ATP was 22- 25 cpm per pmole. The non·atopic skin 
ori g in ated from the following clinica l condi t ions: sca r 
t issu e, psorias is, carcinoma of the breast., ichthyosis, 
cystoma, fi xed drug eruption, mycosis fun go ides, ex folia· 
tive d ermatit is, junctional nevus, Kaposi's sa rcoma, con· 
tact dermatit is, vasculi tis, scleroderma, dermatofi · 
brom a, melanoma, and unin volved skin from atop ic 
de rm a titis. 
p at ie n ts. It is evident that t he protein kin ase 
acti v i ty in individua l samples wi t hin ea ch group 
varie d over a wide ra nge and a ll t issues exa mined 
exhibited a fini te a moun t of enzy me activity both 
in t h e presence a nd in t he a bsence of cyclic AMP. 
T h e m ost s ignificant obse rvation however, was 
t h at, unlike t he enzyme from norma l and non-
atopic controls, the enzy me from atopic skin con· 
sisten t ly displayed li tt le or no stimulation of activo 
ity i n t he prese nce of cyc li c AMP . As indicated in 
F igure 2, the percent stimulation of enzy matic 
acti v i ty in t he presence of cyclic AMP was , fo r 
norm a ls, 130 ± 13 (mean ± SEM) ; for non-a topics , 
115 ± 11 ; a nd for ato pies, 29 - 6. By t he t·test· of 
Stude n t , t he differences between t he controls and 
atopies are s igni ficant (p < 0,001). As shown here, 
cyclic AMP a t 1000·fold higher concentration (5 x 
10 - 3 M) a lso did not elicit a stimulatory response of 
prote in kinase act ivity in atop ic skin . Therefore, 
the p r esence in atopic pa ti ents of a cyc li c AMP-
dep e ndent prot ein kinase(s) wi th modifi ed Km for 
cycl i c AMP seems unlikely. Replace ment of cyc li c 
AM P b y cyclic GMP , cyc lic UMP, or cyc li c CMP 
at c oncen trations of 5 x 10- 6 M was a lso without 
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effect (Fig. 2), suggesti ng t hat t he kinase in atopic 
skin did not have an altered s pecificity wit h 
respect to its cycli c nucleotide requirem ent . Fur-
t hermore, of t he 10 samples of enzymes from t he 
atopic skin tested for cyclic AMP binding, only one 
displayed any measurable a mount of [SH )cyclic 
AMP binding (2.9 picomoles/mg prote in). Prote in 
kinases of normal skin [1 4 ] under s imila r cond i-
t ions bound at least 10 to 20 picomoles of [3H ]cy-
clic AMP per mg protein depend ing upon t he 
prepa ration (data not shown ). 
The res ul ts reported here dev iate from th ose of 
Mier et a l [1 2 ] wi t h rega rd to t he effect of cycl ic 
AMP on prote in kinases from atopic skin. Whether 
this is a resul t of t he assay condi t ions or is due to 
som e other unrecogni zed factors is not clea r to us. 
It is well known t hat cycl ic AMP-dependent 
prote in phos photransferases norma lly ex ist as 
inactive oligomers constructed fro m two ty pes of 
subuni ts: cata lytic a nd regulatory [1 6 ]. Cycli c 
AMP dissoc iates a nd activates t he enzyme by 
binding to t he regulatory subuni t a nd releasi ng t he 
catalytic moiety to perfo rm its fun ction (16 ). T he 
dat a presented here seem to suggest t hat cyclic 
AMP is ineffect ive in sti mulat ing t he prote in 
phosphotra nsferases of atopic skin , probably due 
to a n ap pa rent absence of t he cyclic AMP-b inding 
regu latory subuni t in t hese enzy mes . However, it is 
conceiva bl e t hat t he lack of sti mulation by cyclic 
AMP is a n a rt ifact of iso la tion of t he enzy me from 
small a mounts of t issue resul t ing in t he d issoc iated 
spec ies. Our observations a lso do not spec ify 
whether one or a ll of t he mul t iple forms of cyclic 
AMP-dependent kinases normally present in skin 
[14 ) has been modified in t he atop ic skin . T he 
effect of t he hea t-sta ble inhibi tor of p rotein kin ase 
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F IG. 2. Percent stimulat ion of prote in ki nase acti ,·itv. 
For normal and nO Il ·atop ic skin, the stim ul ation denoted 
is in the presence of 5 x 10- ' M cvclic AMP while for 
atopic skin it is in the presence of: (A ) 5 x 10- ' M 
cyclic AMP; (8) 5 x 10- 3 M cycl ic AMP; (e) 5 x 10 - ' M 
cyclic GMP 0 1' cyclic UMP or cyclic CMP. 
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[16] as well as t hat of cycl ic AMP-binding regula -
tory subunits isolated from normal skin protein 
kinase on the enzyme from atopic skin should 
enable us to resolve these questions. 
Relatively larger amounts of normal and non-
atopic skin have been employed in the extraction 
of protein kinase resulting in enzyme concentra -
tions in the range of 0.7 to 4.9 mg per ml and 0.2 to 
5.8 mg per ml , respectively . In contrast, the atop ic 
biopsies yielded less t issue as the enzyme source 
and therefore lower protein concentrations of 0.2 to 
2.0 mg per m\. Whether t his difference in protein 
concentrat ion has any bearing on our results a lso 
has to be ascertained . 
Since both cycl ic AMP-dependent a nd -inde-
pendent protein kinases have been ident ified in the 
sa me t issue [1 7 ], the atop ic ce lls may have been 
programmed to synthesize one kind exclusively or 
the regulatory subuni t of one may be nonfunc-
tional. A preferential loss of the cyclic AMP-bind-
ing regulatory proteins during purification or t he 
presence of an as yet unknown inhibitor of the bind-
ing proteins in the atopic cells are other possibili-
ties. A definitive elucidation of these a lternatives 
must await the isolation and purification of the 
various isozymes from atopic skin in large enough 
quantities for further analysis . In t his context, it is 
worthwhile to draw attention to t he reports on t he 
identification and isolation of certa in mouse lym-
phoma and rat hepato ma cell s which are defi cient 
in cyclic AMP-binding proteins [18- 20]. More 
recently, mutations affecting one 0 1' both types of 
subunits of cyclic AMP-dependent protein kinase 
in mouse lymphoITla cell s a lso have been dete.cted 
[21]. 
The a uthors t hank Dr. M.Tao for helpful discuss ions. 
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